RUNX1 and hepatocellular carcinoma: For example, Liu et al. demonstrated that RUNX1 exerts an inhibitory effect on vascular endothelial growth factor (VEGF) A in hepatocellular carcinoma, hindering angiogenesis and thus, inhibiting the progression of hepatocellular carcinoma [142].